These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 27772770

  • 1. Lingual protrusion dystonia: Manifestation during "on" periods in Parkinson's disease.
    Maiola R, Ramirez Gómez CC, Micheli F.
    J Neurol Sci; 2016 Nov 15; 370():256-257. PubMed ID: 27772770
    [No Abstract] [Full Text] [Related]

  • 2. Botulinum toxin type A for Levodopa-induced cervical dyskinesias in Parkinson's disease: unfavorable risk-benefit ratio.
    Espay AJ, Vaughan JE, Shukla R, Gartner M, Sahay A, Revilla FJ, Duker AP.
    Mov Disord; 2011 Apr 15; 26(5):913-4. PubMed ID: 21432906
    [No Abstract] [Full Text] [Related]

  • 3. Square-wave action dystonia in Parkinson's disease.
    van den Munckhof P, Lenz FA, Chase TN.
    Mov Disord; 1998 Mar 15; 13(2):354-6. PubMed ID: 9539355
    [No Abstract] [Full Text] [Related]

  • 4. Adductor laryngeal breathing dystonia in a patient with lubag (X-linked dystonia-Parkinsonism syndrome).
    Lew MF, Shindo M, Moskowitz CB, Wilhelmsen KC, Fahn S, Waters CH.
    Mov Disord; 1994 May 15; 9(3):318-20. PubMed ID: 8041372
    [Abstract] [Full Text] [Related]

  • 5. [Pharmacological therapy of complicated Parkinson's disease].
    Jiménez-Jiménez FJ, Molina JA.
    Rev Neurol; 1997 Aug 15; 25 Suppl 2():S170-9. PubMed ID: 9280685
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dystonia.
    Nat Rev Dis Primers; 2018 Sep 20; 4(1):26. PubMed ID: 30237585
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sudden appearance of invalidating dyskinesia-dystonia and off fluctuations after the introduction of levodopa in two dopaminomimetic drug naive patients with stage IV Parkinson's disease.
    Onofrj M, Paci C, Thomas A.
    J Neurol Neurosurg Psychiatry; 1998 Oct 20; 65(4):605-6. PubMed ID: 9771801
    [No Abstract] [Full Text] [Related]

  • 11. A family with hereditary juvenile dystonia-parkinsonism.
    Ishikawa A, Miyatake T.
    Mov Disord; 1995 Jul 20; 10(4):482-8. PubMed ID: 7565830
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Conjugate eye deviations as dyskinesias induced by levodopa in Parkinson's disease.
    LeWitt PA.
    Mov Disord; 1998 Jul 20; 13(4):731-4. PubMed ID: 9686783
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The Movement Disorder Society--14th International Congress of Parkinson's Disease and Movement Disorders.
    Grosset D, Grosset A.
    IDrugs; 2010 Aug 20; 13(8):539-42. PubMed ID: 20721824
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Thirty five years of experience in the treatment of Parkinson's disease with levodopa and associations.
    Chouza C, Buzó R, Scaramelli A, Romero S, de Medina O, Aljanati R, Dieguez E, Lisanti N, Gomensoro J.
    J Neural Transm Suppl; 2006 Aug 20; (70):427-31. PubMed ID: 17017563
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Levodopa-associated hemifacial dystonia.
    Mark MH, Sage JI.
    Mov Disord; 1991 Aug 20; 6(4):383. PubMed ID: 1758464
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.